DNLI logo

DENALI THERAPEUTICS INC

DNLINASDAQ
🏆 #1264 by market capEarnings Nov 4US Equity
$24.69▼ $0.31 (−1.24%)
Market closed · at close
1h—
24h▼ 1.2%
7d▲ 1.0%
14d▲ 3.5%
30d▼ 6.8%
1y▲ 86.6%
🏦Market Cap
$3.92B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
1095.1x
Expensive
Otter Score
58
Weak
📊

Analyst Ratings

Price
$24.69
Total
19
Raised
0
Lowered
0
Avg PT
$34.57
H / L
$41 / $26
InstitutionActionRatingDate
Morgan Stanley
ReiteratedOverweight2026-07-23
Deutsche Bank
ReiteratedBuy2026-07-16
BTIG
ReiteratedBuy2026-05-11
Wedbush
ReiteratedOutperform2026-05-08
Leerink Partners
ReiteratedOutperform2026-04-22
Baird
ReiteratedOutperform2026-04-07
Stifel
ReiteratedBuy2026-03-26
Goldman Sachs
ReiteratedBuy2026-03-26
HC Wainwright & Co.
ReiteratedBuy2026-03-26
JP Morgan
ReiteratedOverweight2025-11-04
Cantor Fitzgerald
ReiteratedOverweight2025-09-08
B of A Securities
ReiteratedBuy2025-05-19
B. Riley Securities
ReiteratedBuy2025-03-05
Oppenheimer
ReiteratedOutperform2025-03-03
Jefferies
ReiteratedBuy2024-11-01
HC Wainwright& Co.
ReiteratedBuy2024-09-04
Citigroup
ReiteratedBuy2024-08-02
UBS
ReiteratedBuy2024-04-09
Evercore ISI Group
ReiteratedOutperform2023-02-28
One row per institution, most recent rating